-
Something wrong with this record ?
Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy
J. Rusz, C. Bonnet, J. Klempíř, T. Tykalová, E. Baborová, M. Novotný, A. Rulseh, E. Růžička,
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT12288
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
ProQuest Central
from 1997-04-01 to 2017-12-31
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-04-01 to 2017-12-31
- MeSH
- Middle Aged MeSH
- Humans MeSH
- Longitudinal Studies MeSH
- Multiple System Atrophy complications MeSH
- Parkinson Disease complications MeSH
- Speech Disorders classification diagnosis etiology MeSH
- Supranuclear Palsy, Progressive complications MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Although speech disorder is frequently an early and prominent clinical feature of Parkinson's disease (PD) as well as atypical parkinsonian syndromes (APS) such as progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), there is a lack of objective and quantitative evidence to verify whether any specific speech characteristics allow differentiation between PD, PSP and MSA. Speech samples were acquired from 77 subjects including 15 PD, 12 PSP, 13 MSA and 37 healthy controls. The accurate differential diagnosis of dysarthria subtypes was based on the quantitative acoustic analysis of 16 speech dimensions. Dysarthria was uniformly present in all parkinsonian patients but was more severe in PSP and MSA than in PD. Whilst PD speakers manifested pure hypokinetic dysarthria, ataxic components were more affected in MSA whilst PSP subjects demonstrated severe deficits in hypokinetic and spastic elements of dysarthria. Dysarthria in PSP was dominated by increased dysfluency, decreased slow rate, inappropriate silences, deficits in vowel articulation and harsh voice quality whereas MSA by pitch fluctuations, excess intensity variations, prolonged phonemes, vocal tremor and strained-strangled voice quality. Objective speech measurements were able to discriminate between APS and PD with 95% accuracy and between PSP and MSA with 75% accuracy. Dysarthria severity in APS was related to overall disease severity (r = 0.54, p = 0.006). Dysarthria with various combinations of hypokinetic, spastic and ataxic components reflects differing pathophysiology in PD, PSP and MSA. Thus, motor speech examination may provide useful information in the evaluation of these diseases with similar manifestations.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010550
- 003
- CZ-PrNML
- 005
- 20181018142212.0
- 007
- ta
- 008
- 160408s2015 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00415-015-7671-1 $2 doi
- 024 7_
- $a 10.1007/s00415-015-7671-1 $2 doi
- 035 __
- $a (PubMed)25683763
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Rusz, Jan $u Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Technická 2, 160 00, Prague 6, Czech Republic, rusz.mz@gmail.com. $7 xx0093732
- 245 10
- $a Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy / $c J. Rusz, C. Bonnet, J. Klempíř, T. Tykalová, E. Baborová, M. Novotný, A. Rulseh, E. Růžička,
- 520 9_
- $a Although speech disorder is frequently an early and prominent clinical feature of Parkinson's disease (PD) as well as atypical parkinsonian syndromes (APS) such as progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), there is a lack of objective and quantitative evidence to verify whether any specific speech characteristics allow differentiation between PD, PSP and MSA. Speech samples were acquired from 77 subjects including 15 PD, 12 PSP, 13 MSA and 37 healthy controls. The accurate differential diagnosis of dysarthria subtypes was based on the quantitative acoustic analysis of 16 speech dimensions. Dysarthria was uniformly present in all parkinsonian patients but was more severe in PSP and MSA than in PD. Whilst PD speakers manifested pure hypokinetic dysarthria, ataxic components were more affected in MSA whilst PSP subjects demonstrated severe deficits in hypokinetic and spastic elements of dysarthria. Dysarthria in PSP was dominated by increased dysfluency, decreased slow rate, inappropriate silences, deficits in vowel articulation and harsh voice quality whereas MSA by pitch fluctuations, excess intensity variations, prolonged phonemes, vocal tremor and strained-strangled voice quality. Objective speech measurements were able to discriminate between APS and PD with 95% accuracy and between PSP and MSA with 75% accuracy. Dysarthria severity in APS was related to overall disease severity (r = 0.54, p = 0.006). Dysarthria with various combinations of hypokinetic, spastic and ataxic components reflects differing pathophysiology in PD, PSP and MSA. Thus, motor speech examination may provide useful information in the evaluation of these diseases with similar manifestations.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a longitudinální studie $7 D008137
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a multisystémová atrofie $x komplikace $7 D019578
- 650 _2
- $a Parkinsonova nemoc $x komplikace $7 D010300
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a poruchy řeči $x klasifikace $x diagnóza $x etiologie $7 D013064
- 650 _2
- $a progresivní supranukleární obrna $x komplikace $7 D013494
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bonnet, Cecilia $7 xx0208282
- 700 1_
- $a Klempíř, Jiří $7 xx0081730
- 700 1_
- $a Tykalová, Tereza $7 _AN089882
- 700 1_
- $a Baborová, Eva $7 xx0192811
- 700 1_
- $a Novotný, Michal $7 ctu2018985794
- 700 1_
- $a Rulseh, Aaron Michael $7 xx0243723
- 700 1_
- $a Růžička, Evžen, $d 1957- $7 jo20000074065
- 773 0_
- $w MED00002835 $t Journal of neurology $x 1432-1459 $g Roč. 262, č. 4 (2015), s. 992-1001
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25683763 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20181018142712 $b ABA008
- 999 __
- $a ok $b bmc $g 1113979 $s 934918
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 262 $c 4 $d 992-1001 $e 20150217 $i 1432-1459 $m Journal of neurology $n J Neurol $x MED00002835
- GRA __
- $a NT12288 $p MZ0
- LZP __
- $a Pubmed-20160408